Understanding Endocannabinoid Receptors

Explore how CB1 & CB2 receptors in the endocannabinoid system affect key physiological processes.

Welcome back to our ongoing series on the introduction to the Endocannabinoid System. In our previous segment, we provided a basic introduction to the ECS (endocannabinoid system) functions. In this segment we will be discussing the different receptors of the ECS, including their locations, functions, and signalling that make the therapeutic potential of cannabinoids a possibility.

 

CANNABINOID RECEPTORS

As mentioned in our previous segment the first cannabinoid receptor, aptly named the CB1 receptor, was first discovered in the late 1980s. Since then, researchers have learned a great deal about cannabinoid receptors, with the two most discussed and most abundantly found in the human body being the CB1 and CB2 receptors. These cannabinoid receptors fall under a classification of cell membrane receptors known as G protein coupled receptors and are responsible for the effects of cannabinoids, including CBD (cannabidiol) effects.

Cannabinoid receptor activation occurs following the introduction of ligands from one or more of three groups.

  • Endocannabinoids – Cannabinoids produced and released within the body.
  • Phytocannabinoids – Plant based cannabinoids such as those found in cannabis.
  • Synthetic cannabinoids – Manufactured pharmaceutical synthetic THC and CBD.

Receptor Signalling

What makes the process of cannabinoid receptor signalling unique is that it is presynaptic. This means that unlike in the case of neurotransmitters that travel from a neuron to a postsynaptic cell, cannabinoids attach to cannabinoid receptors located on the presynaptic neuron and effect ECS (endocannabinoid system) functions. Due to this presynaptic process, the therapeutic potential of cannabinoids can lead to a direct effect on neurotransmission.

Diagram showing the signaling process of CB1 & CB2 cannabinoid receptors in the human body.

LOCATIONS & FUNCTIONS

In a slight over-simplification, cannabinoids and cannabinoid receptors work similar to a lock and a key in that certain cannabinoids will ‘fit’ or bind with their matching receptors, creating CBD (cannabidiol) effects as well as other cannabinoids’ effects. The body’s ECS consists of a vast network of these cannabinoid receptors or ‘locks’. In fact, the CB1 receptor is one of the most abundant receptors found in the brain and in the central nervous system and plays a key role in ECS (endocannabinoid system) functions.

Cannabinoid receptors can be found throughout the body, and are primarily concentrated in the brain, spinal cord, and the tissues of the immune system to help activate the therapeutic potention of cannabinoids.

Much is still to be explored to fully understand ECS (endocannabinoid system) functions and its network of receptors. While there is still ongoing investigation and debate, research has shown that activation of the CB1 and CB2 receptors can influence many of the different systems and functions of the body. The popularity of CBD (cannabidiol) effects is on the rise for this reason. 

CB1 RECEPTORS

Pain

Inflammation

Metabolism / Appetite

Sleep Cycle

Cardiovascular Functions

Mood

Learning & Memory

Neurodegeneration

Addiction

Musculoskeletal Disorders

Reward

Liver Function

Neuroinflammation

Bone Mass

Reproductive Functions

CB2 RECEPTORS

Immune Response

Pain

Inflammation

Neurological Function

Stress Responses

Mood

Addiction

Reproductive Function

 

Detailed infographic on human endocannabinoid system, with light blue & Dark blue dots for CB1 & CB2 receptors respectively.

SECONDARY CANNABINOID RECEPTORS

While research is limited on receptors of the ECS other than the CB1 and CB2 receptors, other receptors do exist that might contribute in the therapeutic potential of cannabinoids, with the two most notable being:

  • Transient Receptor Potential Channels (TRPV-1) – Membrane proteins involved in the modulation of ion entry.
  • Peroxisome Proliferator Activated Receptors (PPARS) – A group of nuclear hormone receptors.

UP NEXT – In the next segment of our series covering the Endocannabinoid System, we will be discussing the endocannabinoids Anandamide (AEA) and 2-Arachidonoylglycerol (2-AG).

 


To begin your cannabis medicine journey today, book an appointment now with the Savikalpa Virtual Clinic for an online doctor consultation, or request more information from a member of our highly trained clinic staff (eclinic@savikalpa.com).

We pride ourselves on being one of India’s most qualified sources of fast, friendly, and professional access to cannabinoid medicine online!


Interested in learning more? Send us your questions (eclinic@savikalpa.com). It is our mission to educate patients in any way we can, and we would be delighted to hear from you.


Research regarding the endocannabinoid system:


DISCLAIMER – All individuals accessing this site undertake full responsibility for their own assessment of the accuracy/relevance of any and all content found herein. The content found on this site is not intended to serve as a substitute for medical advice/diagnosis/treatment from a qualified and licensed health care provider. This information should also in no way be misconstrued as professional legal advice regarding legislative, regulatory or any other matters. Individuals should always seek guidance of fully qualified professionals.